Skip to main content
PrECOG 0105: Final efficacy results from a phase II study of gemcitabine and carboplatin plus iniparib (BSI-201) as neoadjuvant therapy for triple-negative and BRCA1/2 mutation-associated breast cancer American Society of Clinical Oncology Annual Meeting Telli, M. L., Jensen, K., Kurian, A. W., et al 2013